Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors

Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors L. Schirosi1, N. Nannini2, D. Nicoli3, A. Cavazza4, R. Valli4, S. Buti5, L. Garagnani1, G. Sartori1, F. Calabrese2, A. Marchetti6, F. Buttitta6, L. Felicioni6, M. Migaldi1, F. Rea7, F. Di Chiara7, M. C. Mengoli1 & G. Rossi1* Section of Pathologic Anatomy, University Clinic Policlinico of Modena, Modena; Department of Diagnostic Medical Sciences and Special Therapies, Special Pathological Anatomy Section, University of Padua Medical School, Padova; Laboratory of Molecular Biology, Hospital St. Maria Nuova, Reggio Emilia; Section of Pathologic Anatomy, Hospital St. Maria Nuova, Reggio Emilia; Oncology Division, Hospital of Cremona, Cremona; Center of Predictive Molecular Medicine, Center of Excellence on Aging, University of Chieti, Chieti; Division of Thoracic Surgery, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua Medical School, Padova, Italy